Bcr-Abl Kinase Domain Mutations and Other Mutations on the Response to Nilotinib in Bcr Abl –Positive Chronic Myeloid Leukemia - a Study from Eastern India [PDF]
Susana Banerjee +5 more
openalex +1 more source
Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. [PDF]
To determine the functional importance of Ras in transformation by Abl oncogenes, we used a genetic approach to measure the effect of impaired Ras activity on the ability of Bcr-Abl or v-Abl to transform cells.
McLaughlin, J, Sawyers, CL, Witte, ON
core
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin. [PDF]
Kayser S +13 more
europepmc +1 more source
Long‐term molecular remission with persistence of
Giovanni Riva +20 more
openalex +1 more source
Impending Cardiac Tamponade as the Initial Manifestation of BCR-ABL Positive Chronic Myeloid Leukemia. [PDF]
Moursy S +4 more
europepmc +1 more source
Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336 [PDF]
Anja Reichert +3 more
openalex +1 more source
This symposium was dedicated to discussing BCR-ABL-positive chronic myeloid leukaemia (CML) and Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL).
Michele Baccarani +4 more
doaj
T-Lymphoblastic Leukemia With t(9;22): Blast Phase of Chronic Myelogenous Leukemia or BCR-ABL- Positive T-Acute Lymphoblastic Leukemia? [PDF]
Jie Xu, Shaoying Li
openalex +1 more source
Retraction Note: Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin. [PDF]
Wu LX +6 more
europepmc +1 more source
This review aims to discuss similarities and dissimilarities between BCR::ABL1-rearranged (Philadelphia chromosome-positive [Ph+]) and ABL-class fusion-driven BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL) in children and adolescents. Recent
Sarah K. Tasian +2 more
doaj +1 more source

